Passage Bio Inc (PASG) saw a notable increase in its market cap to $37.87 million on Tuesday, with shares opening at $0.69, marking a 3.51% rise from the previous day's closing price of $0.67. The shares hit a high of $0.7199 and a low of $0.6615 during the day. This substantial growth comes despite the company's relatively small workforce size of only 85 people.
The company's average annual earnings per share stand at 22.27%, with a float of $35.17 million and outstanding shares reaching 54.61 million. Insider ownership within Passage Bio Inc. is significant at 35.84%, while institutional ownership stands at 21.42%.
On July 28, the CFO sold 11,453 shares at $0.88, reducing his total shares to 23,994. Earlier on June 28, a major shareholder purchased 575,195 shares for $0.84, totaling $483,164 and raising his total shareholding to 8,034,000 shares.
On June 29, the company reported an EPS of -$0.44 for the last quarter, surpassing the consensus outlook by $0.04 and achieving a return on equity of -52.35%. Analysts predict earnings of -0.42 per share during the current fiscal year and around 22.27% per share in the next fiscal year.
Trading performance indicators for Passage Bio Inc. show a quick ratio of 7.73 for the recent quarter and a diluted EPS of -2.05 over the trailing twelve months, predicted to hit -0.46 in the next quarter and -1.22 in one year's time.
Technical shows a volume increase from 0.2 million to 0.5 million in the last five days, a stochastic %D of 51.53% over the previous nine days, and an Average True Range of 0.05.
In other news, Kellanova Co's (NYSE: K) stock hit a weekly high of $54.00 on Tuesday, reflecting a daily price appreciation of 3.3%. Despite a year-to-date slump of -21.88%, the stock has shown a five-day growth of 3.20%. In Wednesday's trading session, Kellanova Co recorded a volume of 1.48 million shares and a beta value of 0.43, indicating lower volatility than the market average. The share price stood at $52.22, marking an increase of $1.32 or 2.59% from the last close, leading to a market valuation of $17.88B.
Analysts have assigned Kellanova Co's stock a consensus recommendation rating of Hold with a mean score of 2.80 and set a price target of $59.88, suggesting a required rise of 12.79% from its current value for bullish sentiment.
The company is expected to release its quarterly earnings report today, with projected earnings per share equivalent to that of AT&T Inc (NYSE:T). Over the past five years, Kellanova Co has experienced a negative earnings growth rate of -4.86%. However, a -2.93% increase is forecasted for 2023, with a positive annual growth outlook of 2.21% over the next five years.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.